Fidson Healthcare, a leading pharmaceutical firm in Africa largest economy has continued to remain profitable in a sector hobbled by tough operating and macro conditions.
For the first nine months through September 2015, Fidson’s net income increased by 2 percent to N473.48 million, from N466.48
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
BusinessDay
Nigeria's leading finance and market intelligence news report. Also home to expert opinion and commentary on politics, sports, lifestyle, and more
